BWA
KRRO icon

Basecamp Wealth Advisors’s Korro Bio KRRO Stock Holding History

Basecamp Wealth Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$593 Buy
45
+20
+80% +$248 ﹤0.01% 1609
2026
Q1 		$283 Buy
+25
New +$275 ﹤0.01% 1828

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Basecamp Wealth Advisors's KRRO Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Korro Bio (KRRO) stake by 80% in Q2 2026, buying an estimated $248 and bringing the position to 45 shares worth $593. The position accounts for ﹤0.01% of the portfolio, ranked #1609.

Basecamp Wealth Advisors first reported a position in KRRO in Q1 2026 and has held it in 2 quarters since. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Basecamp Wealth Advisors held 45 shares of Korro Bio worth $593 as of Q2 2026.
  • Basecamp Wealth Advisors bought 20 Korro Bio shares in Q2 2026, an estimated $248.
  • Korro Bio made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1609 holding.
  • Basecamp Wealth Advisors first reported a position in Korro Bio in Q1 2026 and has held it in 2 quarters since.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.